Skip to main content
. Author manuscript; available in PMC: 2010 May 1.
Published in final edited form as: Clin Immunol. 2009 Jan 25;131(2):260–270. doi: 10.1016/j.clim.2008.12.001

Figure 5. CD4+CD25+ T cells from GM-CSF-treated mice delay splenocyte-adoptive transfer induced hyperglycemia in NOD-Scid mice.

Figure 5

Splenocytes from 16-20-week-old diabetic mice were transferred i.v into 6-week-old NOD scid mice (n=5; 5×106 cells/mouse) either alone (control) or with CD4+CD25+ T cells (1×106/mouse) from pre-diabetic GM-CSF-treated or untreated (naïve) non-diabetic female NOD mice. Blood glucose levels were monitored weekly. Recipient mice were considered diabetic when glucose levels remained above 250 mg/dL for 2 consecutive weeks. Log-rank test was carried out to determine statistical significance.